Sait Mulamahmutoglu
Istanbul University
4 Papers
9 Citations
Sait Mulamahmutoglu is an academic researcher from Istanbul University. The author has contributed to research in topics: Retrospective cohort study & Mortality rate. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.
Nurdan Kokturk,Cenk Babayiğit,Seval Kul,Pelin Duru Çetinkaya,Sibel Atis Nayci,Serap Argun Baris,Oguz Karcioglu,Pinar Aysert,Ilim Irmak,Aycan Yüksel,Yonca Sekibag,Oya Baydar Toprak,Emel Azak,Sait Mulamahmutoglu,Caglar Cuhadaroglu,Aslihan Demirel,Buğra Kerget,Burcu Baran Ketencioglu,Hasan Selçuk Özger,Gulcihan Ozkan,Zeynep Ture,Begüm Ergan,Vildan Avkan Oğuz,Oguz Kilinc,Merve Ercelik,Tansu Ulukavak Çiftçi,Ozlem Alici,Esra Nurlu Temel,Ozlem Ataoglu,Asena Aydin,Dilek Cetiner Bahcetepe,Yusuf Taha Gullu,Fusun Fakili,Figen Deveci,Neslihan Kose,Muge Meltem Tor,Gulsah Gunluoglu,Sedat Altin,Teyfik Turgut,Tibel Tuna,Önder Öztürk,Oner Dikensoy,Pınar Yıldız Gülhan,Ilknur Basyigit,Hasim Boyaci,I. Kivilcim Oguzulgen,Sermin Borekci,Bilun Gemicioglu,Firat Bayraktar,Osman Elbek,Ismail Hanta,Hacer Kuzu Okur,Gulseren Sagcan,Oguz Uzun,Metin Akgun,Goksel Altinisik,Berna Dursun,Ebru Çakır Edis,Erkmen Gülhan,Fusun Oner Eyuboglu,Okkes Gultekin,Yavuz Havlucu,Metin Özkan,Aysin Sakar Coskun,Abdullah Sayiner,Ali Fuat Kalyoncu,Oya Itil,Hasan Bayram +67 more
TL;DR: In this paper, a multicenter registry study was designed to evaluate the mortality rate and the related risk factors in Turkey in the early phase of the COVID-19 pandemic and found that those patients with male sex, severe pneumonia, multiorgan dysfunction, malignancy, sepsis and interstitial lung diseases were at increased risk of mortality.
44
Tocilizumab in COVID-19: The Cerrahpasa-PREDICT score.
Ahmet Emre Eskazan,Ilker Inanc Balkan,Kaan Can Demirbaş,Muhlis Cem Ar,Ridvan Karaali,Yonca Sekibag,Sait Mulamahmutoglu,Guleren Yartas Dumanli,Fatih Çakmak,Nurgul Ozgur Yurttas,Furkan Kurt,Seda Aladag Kurt,Mert Ahmet Kuşkucu,Seval Ürkmez,Sermin Borekci,Devrim Saribal,Bilgul Mete,Isil Bavunoglu,Yalım Dikmen,Gökhan Aygün,Kenan Midilli,Fehmi Tabak +21 more
TL;DR: In this article, the authors proposed a new clinical scoring system using clinical and laboratory parameters that would help predicting the 28-day mortality of COVID-19 patients receiving tocilizumab.
11
The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort
Cenk Babayiğit,Nurdan Kokturk,Seval Kul,Pelin Duru Cetinkaya,Sibel Atis Nayci,Serap Argun Baris,Oguz Karcioglu,Pinar Aysert,Ilim Irmak,Aycan Akbas Yuksel,Yonca Sekibag,O. Baydar Toprak,Emel Azak,Sait Mulamahmutoglu,Caglar Cuhadaroglu,Aslıhan Demirel,Buğra Kerget,Burcu Baran Ketencioglu,H. Ozger,G. Ozkan,Zeynep Ture,Begüm Ergan,Vildan Avkan Oğuz,Oguz Kilinc,Merve Ercelik,Tansu Ulukavak Çiftçi,Ozlem Alici,Esra Nurlu Temel,Ozlem Ataoglu,Asena Aydin,Dilek Cetiner Bahcetepe,Yusuf Taha Gullu,Fusun Fakili,Figen Deveci,Neslihan Kose,Müge Meltem Tor,Gulsah Gunluoglu,Sedat Altin,Teyfik Turgut,Tibel Tuna,Onder Ozturk,Oner Dikensoy,Pinar Yildiz Gulhan,Ilknur Basyigit,Hasim Boyaci,I. Kivilcim Oguzulgen,Sermin Borekci,Bilun Gemicioglu,Firat Bayraktar,Osman Elbek,Ismail Hanta,Hacer Kuzu Okur,Gulseren Sagcan,Oguz Uzun,Metin Akgun,Goksel Altinisik,B. Dursun,Ebru Çakır Edis,E. Gulhan,Fusun Oner Eyuboglu,O. Gultekin,Yavuz Havlucu,Metin Ozkan,Aysin Sakar Coskun,Abdullah Sayiner,Ali Fuat Kalyoncu,Oya Itil,Hasan Bayram +67 more
TL;DR: It was demonstrated that antiviral drugs including lopinavir, ritonavir, and favipiravir were associated with negative clinical outcomes such as increased risks for lengthy hospital stay, ICU admission, and invasive mechanical ventilation requirement.
4
Post−discharge mortality in the first wave of COVID−19 in Turkey
Fusun Fakili,Pelin Duru Cetinkaya,Oya Baydar,Serap Argun Baris,Nurdan Kokturk,Seval Kul,Oguz Karcioglu,Pinar Aysert Yildiz,Ilim Irmak,Yonca Sekibag,Emel Azak,Sait Mulamahmutoglu,Caglar Cuhadaroglu,Buğra Kerget,Burcu Baran Ketencioglu,H. Ozger,G. Ozkan,Zeynep Ture,Merve Ercelik,Tansu Ulukavak Çiftçi,Ozlem Alici,Esra Nurlu Temel,Ozlem Ataoglu,Neslihan Kose,Müge Meltem Tor,Gulsah Gunluoglu,Sedat Altin,Onder Ozturk,Pınar Yıldız Gülhan,Ilknur Basyigit,Hasim Boyaci,I. Kivilcim Oguzulgen,Sermin Borekci,Bilun Gemicioglu,Ismail Hanta,Hacer Kuzu Okur,Gulseren Sagcan,Metin Akgun,Ali Fuat Kalyoncu,Oya Itil,Hasan Huseyin Bayram +40 more
TL;DR: In this paper , the authors analyzed the data of 18 of 26 centers included in the first TTD-TURCOVID study, and 1 112 cases diagnosed with COVID-19 between 11 March and 31 July 2020 participated in the study.